Exact Sciences Opens New Lab
Exact Sciences opened its new 169,000-square foot clinical lab on the west side of Madison this week, the company announced recently. “Madison, Wisconsin is the home of earlier cancer detection,”…
Category Archives: Biotech
SHINE, Phoenix Achieve Milestone
SHINE and Phoenix have completed a 132-hour test of the high-flux Phoenix neutron generator that helps to prove the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process, the companies…
Propeller Health, Cleveland Clinic Partner
Propeller Health and the Cleveland Clinic have partnered on a COPD study, the company announced today. According to a release, research using Propeller’s platform shows that digital medicines reduced hospital visits…
Promega, BioIVT Partner
Promega has partnered with BioIVT, a provider of research models and services for drug and diagnostic development, the company announced today. According to a release, BioIVT will offer Promega Immune…
Exact Sciences, Mayo Clinic Report Initial Results
Exact Sciences, along with the Mayo Clinic, reports that early research using blood-based methylated DNA markers demonstrate a potential to achieve 92% sensitivity and 92% specificity for detecting the most…
Cellectar Biosciences Receives $10M
Cellectar Biosciences announced today it has entered into definitive agreements with institutional investors to purchase approximately $5 million in a registered direct offering of 1,982,000 common shares and approximately $5…
SHINE, IOCB Prague Collaborate
SHINE has entered into an intellectual property license agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), the company announced today. According to a release,…
SHINE Breaks Ground on Larger Facility
SHINE Medical Technologies broke ground today on a 43,000-square foot production facility, which sits on the land recently donated by the city of Janesville, the company announced today. “Construction of…
Nimble Therapeutics Spins Out of Roche
Nimble Therapeutics announced today that it has spun out from F. Hoffman-La Roche as a standalone biotech company. According to a release, Nimble Therapeutics will commercialize its proprietary chemical synthesis technology for…
Phoenix Secures $4M in Funding
Phoenix has secured $4 million in funding from the U.S. Army to demonstrate neutron-based methods of nondestructive testing, the company announced today. “With N-ray and X-ray capabilities merged, the technology Phoenix…
